UK’s ClearBank plots international expansion with four new board appointments
ClearBank Group Holdings, the parent company of clearing and embedded banking platform ClearBank, has appointed four new non-executive directors as it looks to build out its business and drive its planned international expansion.
ClearBank makes four new appointments to its board
The first appointment is Peter Herbert who, boasting “extensive executive and board experience” as the current chair of Bank of Ireland, has now been designated as the chair of ClearBank Group. He describes ClearBank as “a flagship fintech success story”, and is expected to leverage his focus on retail and commercial banking to deliver new growth for the group.
Joining Herbert is Tim Wade, who joins the group’s audit committee as a senior independent director and group chair. In tandem with this, he is to continue chairing the audit committees of both Royal Bank of Canada Europe and Virgin Money.
According to Wade, ClearBank Group is “new enough to be innovative”, and he hopes to help guide the firm as it “breaks new ground”.
The group’s third appointment is Richard Anderson, who joins as group chair of the risk committee. Until recently, he served as the non-executive chair at Banking Competition Remedies, while also having previously held the position of chair of Pay.UK’s risk committee.
Anderson claims that he has “no doubt” the bank will be able to replicate its success in the UK within new markets internationally, and that despite economic headwinds, it “continues on a path of accelerated growth and profitability“.
The group’s fourth appointment is Susanne Hannestad, who alongside her current board positions at Triodos Bank, Monty Mobile Ltd, Crunchfish and Zimpler, joins ClearBank as a non-executive director.
Hoping to bring “a deep understanding of global cultures, regulatory environments and operating practices” to her new role, Hannestad says that ClearBank is “on the cusp of a period of significant transformation”.
All of the appointments remain subject to regulatory approval.
